InvestorsHub Logo

Cindylou822

02/24/22 5:13 PM

#204497 RE: HyGro #204494

FDA wanted that dosing at a time Bruce Patterson was making a false patent claim for leronlimab dosing for Covid 19.

SF Anony

02/25/22 10:58 AM

#204570 RE: HyGro #204494

The company agreed to the protocol because the FDA has final authority. If they didn’t agree to the protocol, there would’ve been no trial. There is ample proof that the company believed 4 doses was the appropriate dosing and wanted to do the trial that way, but for some mysterious reason the FDA pulled rank and insisted on only 2.

“Agreed” isn’t the correct word. They acquiesced.